Startups
Teijin Limited announced today its establishment of NOMON, Co., Ltd. to sell nutraceutical food and beverages that are scientifically proven to help people maintain their health.
The new incubator, located in Cambridge, Mass., launched with a $150 million Series A financing round.
The new company celebrated the grand opening of its 100-employee Boston facility that will initially focus its efforts on developing oncology therapies.
Verve Therapeutics launched with a $58.5 million Series A financing round. It was led by GV (formerly Google Ventures).
“Team Tarlton” will focus on fundraising for cancer research, support for biking programs, and working to create a vibrant local community
Menlo Park real estate executive takes on the 3,000-mile “Race Across America” bicycle race to raise money for Stanford Cancer Institute
Are you fascinated with microbiology? Have you ever thought about how to integrate your passion for research and entrepreneurship? The field of microbiology is expanding and being significantly impacted by advancements in technology.
The company launched with $6 million in equity funding, which is still open. Betaliq has two compounds in its pipeline, both which use Novaliq’s waterfree EyeSol technology for ophthalmology products.
Start Codon launched in Cambridge, England with funding from keystone investors including Cambridge Innovation Capital, Babraham Bioscience Technologies, Genentech, Jonathan Milner and Ian Tomlinson. Start Codon is a strategic initiative that’s targeting translating research into commercial companies.
The company focuses on developing drugs to treat chronic cough, although their technology may have broader implications for itch, pain and inflammation.
PRESS RELEASES